Insiders Aurinia Pharmaceuticals Inc.

Equities

AUPH

CA05156V1022

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-31 pm EDT			5-day change	1st Jan Change
5.42 ^USD	+0.74%		+4.03%	-39.71%

May. 14	Aurinia Pharmaceuticals Inc. Presented Results from the Analysis Showing Lupkynis A Cost-Effective Treatment for Lupus Nephritis Presented At National Kidney Foundation's Spring Clinical Meeting 2024	CI
May. 07	Lucien Selce Urges Aurinia Pharmaceuticals Board to Take Action to Enhance Shareholder Value	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aurinia Pharmaceuticals Insider Sold Shares Worth $711,094, According to a Recent SEC Filing	Mar. 07	MT
Aurinia Pharmaceuticals Insider Sold Shares Worth $323,372, According to a Recent SEC Filing	Mar. 07	MT
Aurinia Pharmaceuticals Appoints Robert Foster as Part of Deal With Shareholder MKT Capital	23-09-21	MT
Aurinia Pharmaceuticals Appoints Robert T. Foster to its Board	23-09-21	CI
Aurinia Pharmaceuticals Inc. Announces Board Changes	23-08-21	CI
Sector Update: Health Care Stocks Advance Premarket Friday	23-06-30	MT
Aurinia Pharmaceuticals Inc. Announces Board Resignations	23-06-29	CI
Institutional Shareholder Services Inc Recommends Aurinia Shareholders Vote Against the Company’s Named Executive Officers’ Compensation	23-05-03	CI
Insider Sell: Aurinia Pharmaceuticals	23-03-06	MT
Insider Sell: Aurinia Pharmaceuticals	23-03-06	MT
Insider Sell: Aurinia Pharmaceuticals	23-03-06	MT
Insider Buy: Aurinia Pharmaceuticals	22-11-09	MT
Aurinia Pharmaceuticals Inc. Announces Management Departures	22-10-21	CI
Aurinia Pharmaceuticals Names New Chief Commercial Officer As Colao Leaving; Shares Sink	22-07-15	MT
Aurinia Pharmaceuticals' Chief Commercial Officer Max Colao to Leave on July 22	22-07-15	MT
Aurinia Pharmaceuticals Appoints Scott Habig Chief Commercial Officer	22-07-14	MT
Aurinia Announces the Addition of Three Seasoned Executive Leaders to Advance Company Strategy and Performance	22-07-14	CI
Insider Sell: Aurinia Pharmaceuticals	22-03-04	MT
Insider Sell: Aurinia Pharmaceuticals	21-10-26	MT
Insider Sell: Aurinia Pharmaceuticals	21-09-22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Aurinia Pharmaceuticals Inc.

Equities

AUPH

CA05156V1022

Insiders

Filters